SCHEMBL4029619

SCHEMBL4029619

Oc1ccccc1-c1nc(-c2ccc(-c3ccccc3)cc2)nc(-c2ccccc2O)n1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.77
TSHR P16473 2/20 0.77
ADORA3 P0DMS8 1/20 0.77
ALOX15 P16050 1/20 0.77
ADORA2B P29275 1/20 0.77
ADORA1 P30542 1/20 0.77
CASP3 P42574 3/20 0.56
SENP8 Q96LD8 3/20 0.56
SENP7 Q9BQF6 3/20 0.56
SENP6 Q9GZR1 3/20 0.56
CHUK O15111 1/20 0.56
TXNRD1 Q16881 1/20 0.56
NOX4 Q9NPH5 1/20 0.56
ALDH1A1 P00352 3/20 0.56
HSD17B10 Q99714 2/20 0.56
HPGD P15428 2/20 0.56
BCL2L1 Q07817 1/20 0.56
SMN1; SMN2 Q16637 4/20 0.55
MAPK1 P28482 1/20 0.55
LMNA P02545 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1830032 1.00 ADORA2A (0.77) ADORA2ATSHRADORA3ALOX15ADORA2B
SCHEMBL6334711 1.00 ADORA2A (0.77) ADORA2ATSHRADORA3ALOX15ADORA2B
SCHEMBL15908091 1.00 ADORA2A (0.77) ADORA2ATSHRADORA3ALOX15ADORA2B
SCHEMBL15908054 0.98 ADORA2A (0.79) ADORA2ATSHRADORA3ALOX15ADORA2B
SCHEMBL296255 0.96 TSHR (0.82) ADORA2ATSHRADORA3ALOX15ADORA2B
SCHEMBL7577322 0.96 TSHR (0.82) ADORA2ATSHRADORA3ALOX15ADORA2B
SCHEMBL29481861 0.96 TSHR (0.82) ADORA2ATSHRADORA3ALOX15ADORA2B
SCHEMBL15908068 0.94 TSHR (0.79) ADORA2ATSHRADORA3ALOX15ADORA2B
SCHEMBL13938598 0.91 ADORA2A (0.81) ADORA2ATSHRADORA3ALOX15ADORA2B
SCHEMBL15908069 0.90 TSHR (0.74) ADORA2ATSHRADORA3ALOX15ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1213283-B1 Biphenyl-substituted triazines as light stabilisers CIBA HOLDING INC (CH) 2009-04-29 EP disclosed
EP-1213283-B1 Biphenyl-substituted triazines as light stabilisers CIBA HOLDING INC (CH) 2009-04-29 EP disclosed
US-6919454-B2 Biphenyl-substituted triazines CIBA SPECIALTY CHEMICALS CORP. (US) 2005-07-19 US disclosed
US-20050019281-A1 Biphenyl-substituted triazines FLETCHER IAN JOHN (CH) 2005-01-27 US disclosed
US-6841670-B2 High thermal stability, are used as stabilizers for organic polymers to counter damage thereto caused by light, oxygen and heat, as light stabilizers for textile fiber materials and as sunscreens for the human skin. CIBA SPECIALTY CHEMICALS CORPORATION (US) 2005-01-11 US disclosed
US-20030045444-A1 Biphenyl-substituted triazines FLETCHER IAN JOHN (CH) 2003-03-06 US disclosed
US-6468958-B2 LIGHT, OXYGEN AND HEAT RESISTANCE CIBA SPECIALTY CHEMICALS CORPORATION 2002-10-22 US disclosed
EP-0815089-B1 BIPHENYL-SUBSTITUTED TRIAZINES AS LIGHT STABILIZER CIBA SC HOLDING AG (CH) 2002-09-25 EP disclosed
EP-1213283-A2 Biphenyl-substituted triazines as light stabilisers Ciba SC Holding AG (CH) 2002-06-12 EP disclosed
US-20010039341-A1 Biphenyl-Substituted Triazines FLETCHER IAN JOHN (CH) 2001-11-08 US disclosed
US-6255483-B1 USEFUL AS LIGHT STABILIZERS FOR TEXTILE FIBER MATERIALS AND SUNSCREENS FOR HUMAN SKIN CIBA SPECIALTY CHEMICALS CORPORATION 2001-07-03 US disclosed
US-5998116-A TRIAZINE UV ABSORBERS CIBA SPECIALTY CHEMICALS CORPORATION (US) 1999-12-07 US disclosed
EP-0815089-A1 BIPHENYL-SUBSTITUTED TRIAZINES AS LIGHT STABILIZER Ciba SC Holding AG (CH) 1998-01-07 EP disclosed
WO-1996028431-A1 BIPHENYL-SUBSTITUTED TRIAZINES AS LIGHT STABILIZER CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 1996-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050019281-A1 Biphenyl-substituted triazines TYR, AHR, CUTA ADORA2A 3231/4885TSHR 3041/4885ADORA3 4147/4885
US-20030045444-A1 Biphenyl-substituted triazines TYR, CYP1B1, NFE2L2 ADORA2A 3364/4885TSHR 3355/4885ADORA3 4137/4885
US-20010039341-A1 Biphenyl-Substituted Triazines TYR, CYP1B1, NFE2L2 ADORA2A 3364/4885TSHR 3355/4885ADORA3 4137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.